These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Characterisation of tramadol, morphine and tapentadol in an acute pain model in Beagle dogs. Kögel B; Terlinden R; Schneider J Vet Anaesth Analg; 2014 May; 41(3):297-304. PubMed ID: 24576316 [TBL] [Abstract][Full Text] [Related]
7. Effect of the norepinephrine transporter (NET) inhibition on μ-opioid receptor (MOR)-induced anti-nociception in a bone cancer pain model. Ono H; Nakamura A; Kanbara T; Minami K; Shinohara S; Sakaguchi G; Kanemasa T J Pharmacol Sci; 2014; 125(3):264-73. PubMed ID: 24965165 [TBL] [Abstract][Full Text] [Related]
8. Tapentadol hydrochloride: a next-generation, centrally acting analgesic with two mechanisms of action in a single molecule. Tzschentke TM; Jahnel U; Kogel B; Christoph T; Englberger W; De Vry J; Schiene K; Okamoto A; Upmalis D; Weber H; Lange C; Stegmann JU; Kleinert R Drugs Today (Barc); 2009 Jul; 45(7):483-96. PubMed ID: 19834626 [TBL] [Abstract][Full Text] [Related]
9. Tapentadol in pain management: a μ-opioid receptor agonist and noradrenaline reuptake inhibitor. Hartrick CT; Rozek RJ CNS Drugs; 2011 May; 25(5):359-70. PubMed ID: 21476608 [TBL] [Abstract][Full Text] [Related]
10. Miotic and subject-rated effects of therapeutic doses of tapentadol, tramadol, and hydromorphone in occasional opioid users. Stoops WW; Glaser PE; Rush CR Psychopharmacology (Berl); 2013 Jul; 228(2):255-62. PubMed ID: 23430163 [TBL] [Abstract][Full Text] [Related]
11. Tapentadol immediate release: a review of its use in the treatment of moderate to severe acute pain. Frampton JE Drugs; 2010 Sep; 70(13):1719-43. PubMed ID: 20731478 [TBL] [Abstract][Full Text] [Related]
12. Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients. Roulet L; Rollason V; Desmeules J; Piguet V Drugs; 2021 Jul; 81(11):1257-1272. PubMed ID: 34196947 [TBL] [Abstract][Full Text] [Related]
13. Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in mice. Christoph T; Schröder W; Tallarida RJ; De Vry J; Tzschentke TM J Pharmacol Exp Ther; 2013 Dec; 347(3):794-801. PubMed ID: 24051022 [TBL] [Abstract][Full Text] [Related]
14. Tapentadol for pain: a treatment evaluation. Hartrick CT; Rodríguez Hernandez JR Expert Opin Pharmacother; 2012 Feb; 13(2):283-6. PubMed ID: 22192161 [TBL] [Abstract][Full Text] [Related]
17. Ketorolac, Oxymorphone, Tapentadol, and Tramadol: A Comprehensive Review. Vadivelu N; Chang D; Helander EM; Bordelon GJ; Kai A; Kaye AD; Hsu D; Bang D; Julka I Anesthesiol Clin; 2017 Jun; 35(2):e1-e20. PubMed ID: 28526155 [TBL] [Abstract][Full Text] [Related]
18. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution? Candiotti KA; Gitlin MC Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361 [TBL] [Abstract][Full Text] [Related]